Disease-Modifying Drug Possibly Linked to Placental Insufficiency : Severe placental complications in a pregnant woman with multiple sclerosis

Disease-modifying drugs (DMDs) such as interferon (IFN)-β and glatiramer acetate are often prescribed to slow disability progression in patients with multiple sclerosis (MS). However, adverse pregnancy outcomes have been reported with these medications. We report the rare occurrence of severe placen...

Full description

Bibliographic Details
Main Authors: Sultan M. Salahudheen, Muzibunnisa A. Begam
Format: Article
Language:English
Published: Sultan Qaboos University 2016-08-01
Series:Sultan Qaboos University Medical Journal
Subjects:
Online Access:https://journals.squ.edu.om/index.php/squmj/article/view/2169